Evidence map›Paper›PMID 31442033›Full record

ArticleJournal of chemical theory and computation2019

Improving the Efficiency of Ligand-Binding Protein Design with Molecular Dynamics Simulations.

Emilia P Barros, Jamie M Schiffer, Anastassia Vorobieva, Jiayi Dou, David Baker, Rommie E Amaro

Abstract read
In one paragraph

Article in Journal of chemical theory and computation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. bioRxiv : the preprint server for biology · 2023
    Article
  9. Article
  10. Article
  11. The stability and dynamics of computationally designed proteins.Protein engineering, design & selection : PEDS · 2022
    Review
  12. Article
  13. Article
  14. Protein storytelling through physics.Science (New York, N.Y.) · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emilia P Barros
Jamie M SchifferJanssen Pharmaceuticals, Inc. , San Diego , California 92121 , United States.ORCID http://orcid.org/0000-0002-0208-6958
Anastassia Vorobieva
Jiayi Dou
David Baker

Funding

National Biomedical Computation Resource - Competitive Revision SupplementP41GM103426 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AMARO, ROMMIE E · 2012 to 2019
$14.0M
NIGMS NIH HHS P41 GM103426
6 · The paper itself

Abstract

Custom-designed ligand-binding proteins represent a promising class of macromolecules with exciting applications toward the design of new enzymes or the engineering of antibodies and small-molecule recruited proteins for therapeutic interventions. However, several challenges remain in designing a protein sequence such that the binding site organization results in high affinity interaction with a bound ligand. Here, we study the dynamics of explicitly solvated designed proteins through all-atom molecular dynamics (MD) simulations to gain insight into the causes that lead to the low affinity or instability of most of these designs, despite the prediction of their success by the computational design methodology. Simulations ranging from 500 to 1000 ns per replicate were conducted on 37 designed protein variants encompassing two distinct folds and a range of ligand affinities, resulting in more than 180 μs of combined sampling. The simulations provide retrospective insights into the properties affecting ligand affinity that can prove useful in guiding further steps of design optimization. Features indicate that entropic components are particularly important for affinity, which are not easily incorporated in the empirical models often used in design protocols. Additionally, we demonstrate that the application of machine learning approaches built upon the output from the simulations can help discriminate between successful and failed binders, such that MD could act as a screening step in protein design, resulting in a more efficient process.

Indexed as

Molecular Dynamics SimulationBenzyl CompoundsBinding SitesHumansImidazolinesLigandsMachine LearningNucleocytoplasmic Transport ProteinsPregnancy Proteins3,5-difluoro-4-hydroxybenzylidene imidazolinoneBenzyl CompoundsImidazolinesLigandsNucleocytoplasmic Transport ProteinsNUTF2 protein, humanPregnancy Proteins

Identifiers

PMID31442033
PMCPMC7532806

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.